BANK OF MONTREAL /CAN/ - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 32 filers reported holding ONCOCYTE CORP in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q1 2021$12,000
-61.3%
2,246
-77.2%
0.00%
Q4 2020$31,000
+675.0%
9,846
+236.8%
0.00%
Q3 2020$4,0000.0%2,923
-16.0%
0.00%
Q2 2020$4,000
-33.3%
3,481
+27.1%
0.00%
Q4 2019$6,000
+50.0%
2,739
+43.9%
0.00%
Q3 2019$4,0000.0%1,903
+6.1%
0.00%
Q2 2019$4,000
+33.3%
1,794
+33.1%
0.00%
Q3 2018$3,0000.0%1,3480.0%0.00%
Q2 2018$3,0000.0%1,3480.0%0.00%
Q1 2018$3,0001,348
+2543.1%
0.00%
Q4 2017$051
+13.3%
0.00%
Q3 2017$0450.0%0.00%
Q2 2017$045
-55.0%
0.00%
Q2 2016$01000.0%0.00%
Q1 2016$01000.00%
Other shareholders
ONCOCYTE CORP shareholders Q3 2016
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 3,056,680$15,895,0002.92%
IHT Wealth Management, LLC 200$386,0000.19%
Family Management Corp 22,570$117,0000.08%
Artal Group S.A. 150,000$780,0000.01%
Destination Wealth Management 29,656$154,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 145,000$754,0000.01%
Advisor Group, Inc. 102$1,0000.00%
FIFTH THIRD BANCORP 210$1,0000.00%
HUNTINGTON NATIONAL BANK 10$00.00%
AMERICAN INTERNATIONAL GROUP, INC. 2,233$12,0000.00%
View complete list of ONCOCYTE CORP shareholders